Jon Bohane
Directeur Financier/CFO chez Claret Medical, Inc.
Profil
Jon Bohane is currently the Chief Financial Officer at Claret Medical, Inc. and the Chief Operation Officer & General Manager at Ostial Corp.
He previously worked as the Chief Financial Officer at Sadra Medical, Inc., Vice President-Finance & Administration at Access Closure, Inc., Acting Chief Financial Officer at SquareOne, Inc., and Chief Financial Officer at Velomedix, Inc. He obtained an undergraduate degree from San Jose State University.
Postes actifs de Jon Bohane
| Sociétés | Poste | Début |
|---|---|---|
Claret Medical, Inc.
 Claret Medical, Inc. Medical SpecialtiesHealth Technology Claret Medical, Inc. develops a cerebral protection technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions. It focuses on addressing the problem of stroke during transcatheter aortic valve replacement (TAVR), a significant unmet clinical need. The company was founded by Farhad Khosravi and Randy Lashinski in 2009 and is headquartered in Santa Rosa, CA. | Directeur Financier/CFO | - |
Ostial Corp.
 Ostial Corp. Medical/Nursing ServicesHealth Services Ostial Corp. develops catheter-based delivery system combined with a bare metal stent. The firm allows physicians to perform aorto-ostial interventions with precision and predictability. The company was founded by Fred Khosravi in 2008 and is headquartered in Campbell, CA. | Directeur des opérations | 01/03/2019 |
Anciens postes connus de Jon Bohane
| Sociétés | Poste | Fin |
|---|---|---|
Velomedix, Inc.
 Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Directeur Financier/CFO | - |
Sadra Medical, Inc.
 Sadra Medical, Inc. Medical SpecialtiesHealth Technology Sadra Medical, Inc. develops therapies for treatment of aortic valve diseases. The company was founded by Fred Khosravi and Amr Salahieh in 2003 and is headquartered in Marlborough, MA. | Directeur Financier/CFO | - |
SquareOne, Inc.
 SquareOne, Inc. Medical SpecialtiesHealth Technology Squareone, Inc. developed and commercialized medical devices. It developed ostial stenting solutions and lesion-specific interventional systems. The company was founded in 2005 and was headquartered in Mountain View, CA. | Directeur Financier/CFO | - |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Directeur Financier/CFO | - |
Formation de Jon Bohane
| San Jose State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Sadra Medical, Inc.
Sadra Medical, Inc. Medical SpecialtiesHealth Technology Sadra Medical, Inc. develops therapies for treatment of aortic valve diseases. The company was founded by Fred Khosravi and Amr Salahieh in 2003 and is headquartered in Marlborough, MA. | Health Technology |
SquareOne, Inc.
SquareOne, Inc. Medical SpecialtiesHealth Technology Squareone, Inc. developed and commercialized medical devices. It developed ostial stenting solutions and lesion-specific interventional systems. The company was founded in 2005 and was headquartered in Mountain View, CA. | Health Technology |
Velomedix, Inc.
Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Health Technology |
Claret Medical, Inc.
Claret Medical, Inc. Medical SpecialtiesHealth Technology Claret Medical, Inc. develops a cerebral protection technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions. It focuses on addressing the problem of stroke during transcatheter aortic valve replacement (TAVR), a significant unmet clinical need. The company was founded by Farhad Khosravi and Randy Lashinski in 2009 and is headquartered in Santa Rosa, CA. | Health Technology |
Ostial Corp.
Ostial Corp. Medical/Nursing ServicesHealth Services Ostial Corp. develops catheter-based delivery system combined with a bare metal stent. The firm allows physicians to perform aorto-ostial interventions with precision and predictability. The company was founded by Fred Khosravi in 2008 and is headquartered in Campbell, CA. | Health Services |
